(Q74038855)
Statements
Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group (English)
Vincenti F
Kirkman R
Light S
Bumgardner G
Pescovitz M
Neylan J
Wilkinson A
Ekberg H
Gaston R
Backman L